-38.5%
DXCM vs BBIO
+42.7%
-81.3%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.8% | -0.1% | -1.7% | -1.7% |
| 7D | -5.5% | -3.2% | -2.3% | -5.3% |
| 30D | -8.6% | -13.6% | +5.0% | -7.4% |
| 3M | +10.3% | +7.2% | +3.1% | +9.3% |
| 6M | +25.2% | +1.5% | +23.7% | +24.4% |
| YTD | +25.1% | -5.3% | +30.4% | +24.7% |
| 1Y | +9.2% | +37.7% | -28.5% | +4.9% |
| 3Y | -22.6% | +153.9% | -176.5% | -31.1% |
| All | -38.5% | +42.7% | -81.3% | -54.5% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling